Skip to main content
Connect with Us
GDPR
Login for Member Access
Search form
Home
About Us
Membership
Barcelona 2024
Past Meetings
Chicago 2023
Berlin 2022
Chicago 2022
Autumn 2021
Spring 2021
Autumn 2020
Spring 2020
Athens 2019
Chicago 2019
Munich 2018
Chicago 2018
Vienna 2017
Chicago 2017
Lisbon 2016
Chicago 2016
Japan 2015
Chicago 2015
Melbourne 2014
Chicago 2014
London 2013
Chicago 2013
Leiden 2012
Chicago 2012
Milan 2011
Calendar
Event Listing
GCIG Clinical Trials
Bibliography
CCRN Committee
GCIG CCRN Education Symposium, Johannesburg, January 2019
GCIG CCRN Education Symposium, Bucharest, January 2018
GCIG CCRN Education Symposium, Mexico, January 2017
GCIG CCRN Education Symposium, Bangkok, January 2016
Educational Symposia
Harmonization
Resources
Home
/
GCIG Call for Agenda Items - Autumn 2023
GCIG Call for Agenda Items - Autumn 2023
Submitted by
dcc
on Tue, 08/29/2023 - 12:35
GCIG Member Group
*
- Select -
AGO
AGO-AUST
AGOG
ANZGOG
ASCO/HVO - Liaison
ASTRA ZENECA - Pharma-Biotech Partner
B.I.G. - Liaison
BGOG
BRASGYN
CCTG
CEEGOG
COGI-WCRN
CTI
DGOG
EISAI- Pharma-Biotech Partner
ENGOT - Liaison
EORTC-GCG
FIGO - Liaison
GCGS
GCIG Operations
GEICO
GENMAB - Pharma-Biotech Partner
GSK- Pharma-Biotech Partner
G-GOC
GICOM
GINECO
GOG-F
GOTIC
H&N-CIG - Liaison
IGCS - Liaison
IMMUNOGEN - Pharma-Biotech Partner
ISGO
ISGyP - Liaison
ISSTD - Liaison
JGOG
KGOG
KolGOTrg
LACOG-EVA
LungCIG - Liaison
MaNGO
Merck KGaA - Pharma-Biotech Partner
MITO
NCI
NCRI
NOGGO
NSGO-CTU
Observer
PMHC
ROCHE (GENENTECH) - Pharma-Biotech Partner
SGCTG
SGOG
SWISS-GO
World Sarcoma Network - Liaison
ZERIA - Pharma-Biotech Partner
Non-member Director
Country
Project Contact First Name
*
Project Contact Last Name
*
Project Contact Email Address
*
Primary Committee
*
Please select most relevant committee; i.e. Phase II, Rare Tumour, or Translational Research trials must be presented in their respective committee meeting.
- Select -
Operations & Governance Committee
Finance Committee
Membership Committee
Harmonization Ops Committee
Harmonization Stats Committee
Cervix Cancer Committee
CCRN
Phase II Committee
Symptom Benefit Committee
Education Committee
Meta-Analysis Committee
Rare Tumour Committee
Translational Research Committee
Ovarian Cancer Committee
If any additional committee would be relevant for presentation, please indicate:
Operations & Governance Committee
Finance Committee
Membership Committee
Harmonization Ops Committee
Harmonization Stats Committee
Cervix Cancer Committee
CCRN
Phase II Committee
Symptom Benefit Committee
Education Committee
Meta-Analysis Committee
Rare Tumour Committee
Translational Research Committee
Ovarian Cancer Committee
Trial Status
*
Trial Name
*
Trial setting: tumour type/stage
*
Trial Model
*
Academic (A)
Industry (C)
GCIG Groups Involved
Permission to post slide presentation on GCIG website
*
Yes
No